Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 30 * | Sun, 8/3/2014, 2:00 PM - 3:50 PM | CC-254A | |
| Adaptive Designs for Early Phase Studies — Contributed Papers | |||
| Biopharmaceutical Section | |||
| Chair(s): Elena G. Randou (Rantou), FDA | |||
| 2:05 PM | Continual Reassessment Method for a First-In-Human Trial: From Design to Trial Implementation — Inna Perevozskaya, Pfizer ; Lixin Han , Infinity Pharmaceuticals ; Kristen Pierce, Pfizer | ||
| 2:20 PM | Transitioning from 3+3 to N-CRM at GlaxoSmithKline — Sharon Murray, GlaxoSmithKline ; Allison M. Florance, GlaxoSmithKline | ||
| 2:50 PM | Cost-Effectiveness Comparison of Adaptive vs. Equal Randomization for a 'Pick the Winner' Clinical Trial Design — Lingyun Ji, University of Southern California ; Richard Sposto, University of Southern California ; Susan Groshen, University of Southern California | ||
| 3:05 PM | Adaptive Dose Finding Under Model Uncertainty Using MCP-Mod — Tobias Mielke, Aptiv Solutions | ||
| 3:20 PM | Adaptive Designs for Multi-Cohort Early Phase Oncology Trials — Christine Gause, Merck ; Keaven Anderson, Merck | ||
| 3:35 PM | An Adaptive Cohort Up-and-Down Design to Identify Doses with a Low Event Rate When the Study Duration Is Fixed — David Li, Pfizer | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.